patent.fyi
Applications  /  US 2026/0355543
United States Patent Application Publication

US 2026/0355543 A1

Published
Nov 12, 2026
Filed
Jul 9, 2026
Earliest date on the face
Mar 27, 2025
Classification
A61N 7/00
First published here
Nov 19, 2026

Generated automatically. Not reviewed by a person. Not legal advice or an opinion.

Section 1 · machine-generated

What if?

Questions about how individual parts of claim 1 might be changed. A question may describe something different from what the claim language recites, or a version of it; no view is offered on which.

1.1Stand mounted transducer array

What ifWhat if a stand holds the transducer array against the neck during a seated session?
Claim language“a wearable device”

A lockable articulated arm supports the transducer head, and a headrest limits neck movement. A spring-loaded mount maintains contact through a layer of acoustic coupling gel.

1.2Conductive stimulation through skin electrodes

What ifWhat if skin electrodes deliver charge-balanced current pulses?
Claim language“a low-intensity focused ultrasound (LIFU), radiofrequency, or pulsed electromagnetic field energy”

An isolated constant-current driver sends biphasic pulses between two hydrogel electrodes through a conductive path in the tissue. The driver reverses current polarity within each pulse to balance the delivered charge.

1.3Measurements at scheduled pauses

What ifWhat if the controller measures physiological responses only during scheduled pauses in stimulation?
Claim language“continuously monitoring physiological responses”

A timer triggers a recording window before the first stimulation block and after each subsequent block. The controller derives heart rate variability from beat intervals and averages skin conductance within each window.

1.3Separate physiological recording unit

What ifWhat if an independent recorder collects physiological data from adhesive chest electrodes and finger electrodes?
Claim language“via embedded sensors”

The recorder derives beat intervals from the electrocardiogram and measures skin conductance across the finger electrodes. It sends time-stamped measurements over a short-range radio link to the stimulation controller.

1.4Between session parameter updates

What ifWhat if the controller updates stimulation settings between sessions using data from the completed session?
Claim language“adjusting stimulation parameters in real-time”

The controller holds pulse timing and output level constant during each session while recording physiological data. After the session, it compares response summaries with baseline values and stores the next session's settings within preset limits.

Section 2 · machine-generated

Variations

Further arrangements of the same subject matter, described here as of the publication date at the foot of this page.

Other field of use

Closed loop testing in a neck phantom

A wearable collar couples its ultrasound array to a layered neck phantom with an embedded hydrophone at the nominal stellate ganglion location. A physiological signal simulator feeds synthetic heartbeat and skin conductance signals into the collar's sensor inputs. The controller adjusts the pulse train in response to those signals, and a bench recorder captures the hydrophone output alongside the simulated inputs and controller commands.

Component substitution

Optical sensing of pulse intervals

A reflectance photoplethysmography module in an ear clip replaces electrical heartbeat sensing and sends timestamped pulse detections to the collar controller over a wired link. A light emitting diode illuminates the earlobe, and an adjacent photodiode measures changes in reflected light over each pulse. The controller computes pulse rate variability from accepted interbeat intervals and fuses it with skin conductance from the collar electrodes. The controller holds the current stimulation settings when optical signal quality falls below a configured threshold.

Piezoelectric composite ultrasound array

An array of piezoelectric ceramic pillars embedded in a polymer matrix replaces an array of solid ceramic elements in the collar. Each composite element has separate electrodes and a drive channel, with a lossy backing layer behind the array and an acoustic matching layer facing the coupling pad. The drive channels apply calibrated timing delays to focus the emitted pulses while the biometric controller adjusts burst timing through the shared pulse generator.

Parameter or scale variation

Feedback windows with staggered updates

The collar controller maintains a 60-second rolling buffer of heartbeat intervals and a 10-second rolling buffer of skin conductance samples. Every 5 seconds it calculates the root mean square of successive heartbeat interval differences and fits a linear slope to the conductance samples. The controller uses the resulting feature pair to update the requested pulse repetition rate within configured limits. Both buffers must contain a full window of usable data before adjustment begins.

Combination with existing systems

Collar feedback linked to a bedside monitor

A wired gateway receives timestamped beat markers from a bedside multiparameter monitor and pairs them with skin conductance readings from the collar. The gateway aligns the two streams to a shared clock and forwards them with their signal quality flags to the collar controller. The controller uses valid data from both streams to adjust the ultrasound pulse train and pauses emission when the gateway reports a disconnected sensor or stale data.

Automated or data-driven variant

Motion gating for feedback updates

A three-axis accelerometer mounted beside the transducer array streams motion samples to the controller on the same clock as the biometric channels. The controller subtracts a low-pass estimate of gravity and flags windows whose remaining acceleration exceeds a configured threshold. It excludes heartbeat intervals and conductance samples from flagged windows and holds the stimulation settings until both channels supply a fresh usable window.

Specific version of a part

Collar with a sliding carrier

A padded collar carries the transducer array on a sliding carrier with a locking screw. A compliant mount holds the array face against a gel pad as the carrier moves along the collar.

Electronically focused ultrasound bursts

Individual channels drive the piezoelectric elements of the array with short ultrasound bursts. Programmed timing offsets align the emitted waves at the selected focal location.

Embedded optical and conductance sensors

A light-emitting diode and photodiode in the collar continuously record a peripheral pulse waveform, and the processor estimates heart rate variability from pulse intervals. Two skin-contact electrodes in the same collar measure conductance with a small applied voltage.

Bounded updates from rolling measurements

A microcontroller computes rolling averages of skin conductance and rolling estimates of heart rate variability. At each update, it compares both measurements with preset ranges and changes the next burst interval by at most one programmed step.

Section 3 · quoted from USPTO records

Other work

Passages reproduced word for word from two earlier-published U.S. patent documents, placed beside the language of claim 1. No characterization is offered. Each passage is marked A or B for the document it comes from; ¶ numbers are the paragraph numbers in the USPTO’s published full text of that document.

Document AUS 2021/0244951 A1
Published
Aug 12, 2021
Filed
Apr 27, 2021
Class
A61N 1/36114
Document BUS 2024/0157164 A1
Published
May 16, 2024
Filed
Mar 25, 2022
Class
A61N 2/006
Claim 1
Document A
Document B
1.1positioning a wearable device with an integrated transducer array over a stellate ganglion region of a user;
Fourth, a loop or remote suture electrode can be used to place over the stellate ganglion and/or ansa subclavius, or more than one electrode can be targeted along the stellate ganglion and/or ansa subclavius for redundancy and/or diagnostics.
A · US 2021/0244951 A1 · ¶ 10
In order to provide a technical means that offers excellent convenience, usability, and safety for stellate ganglion block that can effectively suppress sympathetic overexcitation, this stellate ganglion magnetic stimulation device comprises: a head unit having a magnet for generating magnetism; and a neck unit that is removably worn around a wearer's neck and that presses the head unit against epidermis corresponding to the stellate ganglion so that stimulation by the magnet
B · US 2024/0157164 A1 · abstract
1.2delivering neuromodulatory stimulation using at least one of a low-intensity focused ultrasound (LIFU), radiofrequency, or pulsed electromagnetic field energy;
For example, it is possible to use an electromagnet as the magnet 3 (that is, to form a dynamic magnetic field). By changing the magnetic field on the body surface by using a coil, a current is generated in the living body non-invasively to stimulate nerves.
B · US 2024/0157164 A1 · ¶ 92
1.3continuously monitoring physiological responses, including heart rate variability and skin conductance, via embedded sensors;
As a method or procedure for evaluating the adequacy of the wearing position of the magnet 3, it is possible to use a physiological index reflecting the state of the sympathetic nerves, as typified by the heart rate variability analysis system described later. For example, it is possible to construct a system that senses the above physiological index in a relatively short period of time and displays the sensed physiological index.
B · US 2024/0157164 A1 · ¶ 57
1.4adjusting stimulation parameters in real-time using a closed-loop control system based on monitored physiological data; and
The distal or downstream electrode pair forms the sensor-check arm to determine whether delivery was sufficient to affect neural function, and then feeds the gathered information to the primary-sensor arm (with upstream electrodes confirming effect or lack thereof). This constant feedback dose titration can allow much lower outputs of stimulation without the need for a safety margin for paced output and can include two important sequelae of practical value.
A · US 2021/0244951 A1 · ¶ 52
1.5providing adaptive neuromodulation personalized to a user's autonomic response.

An empty cell means only that no passage was reproduced there.

Statements in these documents
Hypertension, commonly known as high blood pressure, is a long-term condition in which the blood pressure is persistently elevated and can affect 16-37% of the population globally.
A · US 2021/0244951 A1 · ¶ 3
For example, this document describes methods and devices for providing stimulation or ablation to the stellate ganglion to modify blood pressure.
A · US 2021/0244951 A1 · ¶ 6
However, the stellate ganglion block injection proposed in Patent Document 1 cannot be readily used outside of medical institutions, and there is a risk of side effects and infection due to direct insertion of the needle into the body.
B · US 2024/0157164 A1 · ¶ 7
Accordingly, an object of the present invention is to provide a technical means that offers excellent convenience, usability, and safety for stellate ganglion block that can effectively suppress sympathetic overexcitation.
B · US 2024/0157164 A1 · ¶ 8
Cite aspatent.fyi, US 2026/0355543 A1, claim 1, first published 2026-11-19T12:45:34-05:00, https://patent.fyi/US20260355543/, SHA-256 30769c0810183087825b5e1531440bd530556dc28cc0684ed2c3e2c64c636bb7
First published
Permanent addresshttps://patent.fyi/US20260355543/
Content fingerprint (SHA-256)30769c0810183087825b5e1531440bd530556dc28cc0684ed2c3e2c64c636bb7
Methodv2026-11-18.2 · automated, not reviewed by a person
Correctionscorrections@patent.fyi